| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 30.90 +58.86% on 04/04/25 |
Period Open: 50.93
| 50.85 -3.46% on 03/26/25 | -1.84 (-3.61%) since 03/25/25 |
| 3-Month | 30.90 +58.86% on 04/04/25 |
Period Open: 55.73
| 82.53 -40.52% on 02/18/25 | -6.64 (-11.91%) since 01/24/25 |
| 52-Week | 22.25 +120.63% on 08/05/24 |
Period Open: 31.65
| 82.53 -40.52% on 02/18/25 | +17.44 (+55.10%) since 04/25/24 |
Here are three large-cap stocks that are well-positioned to deliver outsized gains to investors amid the tariff turmoil in 2025
Block XYZ is expanding its portfolio with the new Square Point of Sale (POS) app that integrates domain specific commerce and payments functionality into a single, unified app that allows sellers to personalize...
In this video, I will be covering two growth stocks that are down over 30% this year. Watch the short video to learn more, consider subscribing, and click the special offer link below.
An updated edition of the February 25, 2025 article.Mobile payments are financial transactions made using smartphones, tablets, or wearable devices, removing the need for cash or physical cards. These...
MSCI MSCI is set to report its first-quarter 2025 results on April 22.For the first quarter of 2025, the Zacks Consensus Estimate for earnings is currently pegged at $3.87 per share, which has declined...
Affirm Holdings, Inc. AFRM and PayPal Holdings, Inc. PYPL are two standout names in the fast-paced world of fintech, or financial technology. Both companies are playing key roles in reshaping how consumers...
Affirm Holdings, Inc. (AFRM) is a financial technology company specializing in payment solutions that provide consumers with flexible, transparent installment loans — both interest-free and interest-bearing...
DocuSign, Inc. DOCU shares have gained 24.3% in the past year, outperforming the 4.5% rise of the industry.Reasons Behind the RallyDocuSign’s top line has been benefiting from continued customer demand...
Affirm Holdings (AFRM) is a Zack Rank #1 (Strong Buy) that is a financial services company that offers "buy now, pay later" solutions, allowing customers to make purchases and pay over time.The company...
Affirm (NASDAQ: AFRM) stock is down significantly due to the broader market sell-off.
Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $20 Call had some of the highest...
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers
Why Corcept (CORT) Shares Are Sliding Today
Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q4 Earnings
Corcept (CORT) Q4 Earnings Report Preview: What To Look For
For Immediate ReleaseChicago, IL – February 3, 2025 – Today, Zacks Equity Research discusses Corcept Therapeutics CORT, Amneal Pharmaceuticals AMRX, Dyne Therapeutics DYN, Nektar Therapeutics NKTR...
The biotech industry has declined since Donald Trump’s election victory. This was mainly because Trump nominated Robert F. Kennedy Jr., a vaccine skeptic, to head the Health and Human Services, the agency...
For Immediate ReleaseChicago, IL – January 30, 2025 – Stocks in this week’s article are OppFi Inc. OPFI, Corcept Therapeutics Inc. CORT, DXP Enterprises Inc. DXPE, Perpetua Resources Corp. PPTA and...
Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $20 Call had some of the highest...
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers
Why Corcept (CORT) Shares Are Sliding Today
Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q4 Earnings
Corcept (CORT) Q4 Earnings Report Preview: What To Look For
For Immediate ReleaseChicago, IL – February 3, 2025 – Today, Zacks Equity Research discusses Corcept Therapeutics CORT, Amneal Pharmaceuticals AMRX, Dyne Therapeutics DYN, Nektar Therapeutics NKTR...
The biotech industry has declined since Donald Trump’s election victory. This was mainly because Trump nominated Robert F. Kennedy Jr., a vaccine skeptic, to head the Health and Human Services, the agency...
For Immediate ReleaseChicago, IL – January 30, 2025 – Stocks in this week’s article are OppFi Inc. OPFI, Corcept Therapeutics Inc. CORT, DXP Enterprises Inc. DXPE, Perpetua Resources Corp. PPTA and...
Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $20 Call had some of the highest...
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers
Why Corcept (CORT) Shares Are Sliding Today
Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q4 Earnings
Corcept (CORT) Q4 Earnings Report Preview: What To Look For
For Immediate ReleaseChicago, IL – February 3, 2025 – Today, Zacks Equity Research discusses Corcept Therapeutics CORT, Amneal Pharmaceuticals AMRX, Dyne Therapeutics DYN, Nektar Therapeutics NKTR...
The biotech industry has declined since Donald Trump’s election victory. This was mainly because Trump nominated Robert F. Kennedy Jr., a vaccine skeptic, to head the Health and Human Services, the agency...
For Immediate ReleaseChicago, IL – January 30, 2025 – Stocks in this week’s article are OppFi Inc. OPFI, Corcept Therapeutics Inc. CORT, DXP Enterprises Inc. DXPE, Perpetua Resources Corp. PPTA and...
| Symbol | %Holdings | 3M %Chg |
|---|---|---|
| AFRM | -11.91% | |
| Affirm Holdings Inc Cl A | ||
| JHMM | 1247.4% | -11.59% |
| JH Midcap Multifactor ETF | ||
| JHML | 231% | -9.05% |
| JH Largecap Multifactor ETF | ||
| IPAY | 3.07% | -12.15% |
| ETFMG Prime Mobile Payments ETF | ||
| IBUY | 2.32% | -10.22% |
| Online Retail Amplify ETF | ||
| XVOL | 1.68% | -11.23% |
| Acruence Active Hedge U.S. Equity ETF | ||
| 3rd Resistance Point | 52.66 |
| 2nd Resistance Point | 51.42 |
| 1st Resistance Point | 50.25 |
| Last Price | 49.09 |
| 1st Support Level | 47.84 |
| 2nd Support Level | 46.60 |
| 3rd Support Level | 45.43 |
| 52-Week High | 82.53 |
| Fibonacci 61.8% | 59.50 |
| Fibonacci 50% | 52.39 |
| Last Price | 49.09 |
| Fibonacci 38.2% | 45.28 |
| 52-Week Low | 22.25 |
Please check your inbox for a link to activate your My Barchart Account.
If you do not receive the email within a few minutes check your spam folder or contact our support team for assistance.
